Navigation Links
New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer
Date:5/31/2008

sterolemia of grade 2 or higher, compared with interferon-alpha (P=0.001), but there was not a significant increase in hyperlipidemia versus interferon-alpha (P=0.675). However, the development of hyperglycemia or hypercholesterolemia did not have affect on overall survival or progression-free survival in this study.

The clinical data for TORISEL presented at the meeting represent only a portion of the totality of the safety and efficacy data from the ongoing clinical development of TORISEL.

About TORISEL

TORISEL is an mTOR inhibitor. Inhibition of mTOR in treated cancer cells blocked the translation of genes that regulate the cell cycle. In in vitro studies using renal cancer cell lines, TORISEL inhibited the activity of mTOR and resulted in reduced levels of certain cell growth factors involved in the development of new blood vessels, such as vascular endothelial growth factor.

TORISEL is approved for the treatment of advanced RCC in the United States, European Union and other markets, based on results of a phase 3 clinical study that demonstrated that TORISEL improves overall survival for patients with advanced RCC compared with interferon-alpha.

Important Safety Information

Hypersensitivity reactions manifested by symptoms, including, but not limited to anaphylaxis, dyspnea, flushing and chest pain have been observed with TORISEL.

Serum glucose, serum cholesterol and triglycerides should be tested before and during treatment with TORISEL.

The use of TORISEL is likely to result in hyperglycemia and hyperlipemia. This may result in the need for an increase in the dose of, or initiation of, insulin and/or oral hypoglycemic agent therapy and/or lipid-lowering agents, respectively.

The use of TORISEL may result in immunosuppression. Patients should be carefully observed for the occurrence of infections, including opportunistic infections.

Cases of interstitial lung disease, some resulting in death,
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting
2. New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG
3. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
4. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
5. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
6. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
7. Data To Be Presented at ASCO Supports Potential of Peregrines Cotara(R) for the Treatment of Brain Cancer
8. About 60 Clinical Studies Regarding Schering-Ploughs Oncology Compounds Will be Presented at ASCO
9. Two DOXIL(R) Studies to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
10. Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration
11. Safety and Efficacy Results Presented From Largest Prospective Controlled Clinical Study of Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 31, 2015   BioLife Solutions , Inc. ... and marketer of proprietary clinical grade cell and ... freeze media and a related cloud ... smart shippers ("BioLife" or the "Company"), ... advanced biopharmaceutical company focused on developing and commercializing ...
(Date:8/30/2015)... 30, 2015 La solución ... l cuidado al paciente a ... Royal Philips  (NYSE: PHG, AEX: ... IntelliSpace Cardiovascular , un sistema web de gestión de ... analizar y compartir imágenes cardiovasculares e información en cualquier ...
(Date:8/28/2015)... , Aug. 28, 2015  Delays in the ... can slow down the decision-making process, resulting in ... absolutely critical for biopharmaceutical companies to develop a ... process for quicker and more meaningful insights. ... Practices, LLC, nearly three-quarters of benchmarked study participants ...
Breaking Medicine Technology:BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 2BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 3BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 5Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3Expediting the Pharmaceutical Market Research Process for Faster Insights 2
... April 21, 2011 Marinus Pharmaceuticals, Inc., the ... nervous system disorders, today announced commencement of a ... for the treatment of posttraumatic stress disorder (PTSD). ... specific neurosteroid recognition site. Neurosteroid levels have been ...
... 21, 2011 Reportlinker.com announces that a new ... Body Contouring Devices - Global ... 2017 http://www.reportlinker.com/p0484508/Body-Contouring-Devices---Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017.html ... Competitive Landscape and Market Forecasts to 2017 ...
Cached Medicine Technology:Marinus Pharmaceuticals Announces Commencement of Phase 2 Trial of Ganaxolone for the Treatment of Posttraumatic Stress Disorder 2Marinus Pharmaceuticals Announces Commencement of Phase 2 Trial of Ganaxolone for the Treatment of Posttraumatic Stress Disorder 3Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 2Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 3Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 4Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 5Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 6Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 7Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 8Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 9Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 10Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 11Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 12
(Date:8/31/2015)... ... 31, 2015 , ... Wound Care Advantage, a leader in ... to Hyperbaric Medicine Course. The next UHMS approved 40-hour Introduction to Hyperbaric Medicine ... Long Beach, CA. The meeting is open for registration from physicians, clinicians and ...
(Date:8/31/2015)... Dayton, Ohio (PRWEB) , ... August 31, 2015 ... ... Jenny Michael as Vice President, Marketing and Corporate Communications. In this capacity, Michael ... , CareSource is an industry leader in consumer-focused programs that have contributed ...
(Date:8/31/2015)... ... August 31, 2015 , ... In an article published August 24th ... Global Open Journal that discusses the future of 3-D printing technology as it relates ... customized implants, prosthetics, and other 3-D printed tools could be used to aid in ...
(Date:8/31/2015)... ... August 31, 2015 , ... NJ Top Docs Presents, Dr. Michael Betsy! Dr. ... Park Ridge, New Jersey, Dr. Michael Betsy graduated from Don Bosco Prep in 1990 and ... as team captain in both sports in his senior year. He was inducted into ...
(Date:8/31/2015)... ... , ... According to an article published August 3rd on Healio, ... underwent bariatric surgery “felt significantly better two years after surgery.” The article goes on ... study felt that their “mental health had been normalized” at the point when the ...
Breaking Medicine News(10 mins):Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 4Health News:CareSource Names Vice President, Marketing and Corporate Communications 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 3Health News:NJ Top Docs Presents, Dr. Michael Betsy! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 3Health News:Article on Adolescent Bariatric Surgery Demonstrates the Powerful Effect of Being in Control, Notes Dr. Michael Feiz 2Health News:Article on Adolescent Bariatric Surgery Demonstrates the Powerful Effect of Being in Control, Notes Dr. Michael Feiz 3
... American Pacific,Corporation (Nasdaq: APFC ) today announced that ... on Thursday, February 7, 2008. John R.,Gibson, Chairman and ... to review the financial results and outlook of the,Company., ... 2008 at 1:30 p.m.,PST. To access the call please ...
... 1 The Chrysler Foundation and,Kenosha (Wis.) Engine Plant ... its new Aquatics Center., Chrysler,s donation will help ... to the YMCA. The center will have two pools: ... The YMCA will break,ground for the aquatic center later ...
... AMES, Iowa An anti-virus drug attacks influenza A by ... for the virus to infect healthy cells, according to a ... , Mei Hong, Iowa States John D. Corbett Professor in ... studying the effects of the antiviral drug amantadine on influenza ...
... Chiltern, the global contract research,organization, announced today that ... a leading Phase 1 unit located at Ninewells,Hospital and ... Kingdom,s major teaching hospitals. The purchase of DDS supplements,Chiltern,s ... was founded in 1982 and has completed more than ...
... and marital status underpin findings of 17-nation study ... factors for suicidal thoughts, plans and attempts are similar ... study, which used data collected by the World Health ... in 17 nations and found that an overall average ...
... succeeded in losing weight in a year-long medically supervised ... increase over that period, say researchers from The Children,s ... is a critical period for bone health in later ... the journal Obesity studied 62 adolescents between the ages ...
Cached Medicine News:Health News:American Pacific to Release Financial Results and Hold Fiscal 2008 First Quarter Investor Teleconference 2Health News:The Chrysler Foundation and Kenosha Engine Plant Donate $100,000 to New YMCA Aquatics Center 2Health News:Iowa State chemists track how drug changes, blocks flu virus 2Health News:Chiltern Announced Today That it has Acquired the Business of Drug Development Solutions (DDS) 2Health News:Chiltern Announced Today That it has Acquired the Business of Drug Development Solutions (DDS) 3Health News:Key Risk Factors for Suicide Consistent Across Globe 2Health News:Bone mineral content continues to increase in obese adolescents during weight loss 2
The Natural Selection family of specialty allografts is spinal concepts response to surgeon requests for spinal allograft devices to eliminate the need for painful autograft harvesting....
Transcranial vascular DWL doppler....
Transcranial vascular DWL doppler....
... Neurocare is a full-featured physiologic testing system offered ... contains many of the features of our flagship ... economical price. , ,The smaller size of the ... environment, the physician's office, a mobile service or ...
Medicine Products: